Takeda Pharmaceutical
292 hedge funds and large institutions have $1.51B invested in Takeda Pharmaceutical in 2021 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 88 increasing their positions, 92 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
4% less funds holding
Funds holding: 304 → 292 (-12)
6% less capital invested
Capital invested by funds: $1.6B → $1.51B (-$92.6M)
24% less first-time investments, than exits
New positions opened: 29 | Existing positions closed: 38
Holders
292
Holding in Top 10
2
Calls
$66.6M
Puts
$23.1M
Top Buyers
| 1 | +$35.6M | |
| 2 | +$32.2M | |
| 3 | +$12M | |
| 4 |
Barclays
London,
United Kingdom
|
+$7.28M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
+$5.65M |
Top Sellers
| 1 | -$33.4M | |
| 2 | -$33.1M | |
| 3 | -$17M | |
| 4 |
GC
GMT Capital
Atlanta,
Georgia
|
-$9.46M |
| 5 |
LP
LMR Partners
London,
United Kingdom
|
-$8.69M |